The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol-Reference-Cited by-同舟云学术

The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol

Published:1994-03 Issue:1-2 Volume:640 Page:246-254
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Higgins Guy. A.,Joharchi Narges,Wang Yephat,Corrigall William A.,Sellers Edward M.

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference75 articles.

1. Brain CCKB receptors mediate the suppression of dopamine release by cholecystokinin;Altar;Brain Res.,1989

2. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats;Bals-Kubik;J. Pharmacol. Exp. Ther.,1993

3. Abuse potential of buspirone and related drugs;Balster;J. Clin. Psychopharmacol.,1990

4. Drug abuse potential evaluation in animals;Balster;Br. J. Addiction,1991

5. Heroin reward is dependent on a dopaminergic substrate;Bozarth;Life Sci.,1981

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heroin and its metabolites: relevance to heroin use disorder;Translational Psychiatry;2023-04-08

2. Neural circuit mechanisms of the cholecystokinin (CCK) neuropeptide system in addiction;Addiction Neuroscience;2022-09

3. Medications development for food-based and drug use disorders;Advances in Pharmacology;2019

4. The unappreciated roles of the cholecystokinin receptor CCK(1) in brain functioning;Reviews in the Neurosciences;2017-07-26

5. Acetaldehyde Oral Self-Administration: Evidence from the Operant-Conflict Paradigm;Alcoholism: Clinical and Experimental Research;2012-02-10